New Key Statistics Module, Z-Score and F-Score
OTCPK:CYTOF Key Ratios
| Market Cap $ M | 0.65 |
| Enterprise Value $ M | 1.04 |
| P/E(ttm) | 0.36 |
| PE Ratio without NRI | 0.42 |
| Forward PE Ratio | -- |
| Price/Book | 0.07 |
| Price/Sales | 1.36 |
| Price/Free Cash Flow | 0.03 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | 0.48 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 72.50 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.46 |
| EV-to-EBITDA | -0.47 |
| PEG | 0.01 |
| Shares Outstanding M | 3.78 |
| Net Margin (%) | -273.40 |
| Operating Margin % | -1,113.30 |
| Pre-tax Margin (%) | -1,091.49 |
| Quick Ratio | 0.43 |
| Current Ratio | 0.43 |
| ROA % (ttm) | -9.22 |
| ROE % (ttm) | -36.91 |
| ROIC % (ttm) | -37.48 |
| Dividend Yield % | -- |
| Altman Z-Score | -22.16 |
CYTOF Number of Guru Trades
CYTOF Volume of Guru Trades
Gurus Latest Trades with OTCPK:CYTOF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CYTOF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Altamira Therapeutics Ltd Insider Transactions
No Available Data
News about OTCPK:CYTOF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers